未登录

X

Xuefeng Qiu

Nanjing University

H指数:30

被引数:3,782

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Patient-derived organoids based on targeted biopsy of primary prostate cancer: development, identification, and drug screening

基于对原发性前列腺癌进行靶向活检的病人来源类器官：开发、鉴定和药物筛选

Annals of Medicine

IF4.3

2025-12-160

OAAI

Neoadjuvant darolutamide plus androgen deprivation therapy for high-risk and locally advanced prostate cancer: a multicenter, open-label, single-arm, phase II trial

新辅助达罗鲁胺联合雄激素剥夺疗法治疗高危及局部晚期前列腺癌：一项多中心、开放标签、单臂、II期临床试验

WORLD JOURNAL OF UROLOGY

IF2.9

2025-01-030

PRE

A student trained convolutional neural network competing with a commercial AI software and experts in organ at risk segmentation

SCIENTIFIC REPORTS

IF3.9

2024-10-290

OAAI

The Value of 68 Ga-PSMA PET/MRI for Classifying Patients with PI-RADS 3 Lesions on Multiparametric MRI A Prospective Single-Center Study

68 ga-psma PET/MRI在多参数MRI上对PI-RADS 3病变患者进行分类的价值: 前瞻性单中心研究

JOURNAL OF NUCLEAR MEDICINE

IF9.1

2024-03-143

OA

Comparison of clinical and radiological features-based and radiomics features-based models for pulmonary nodule malignancy prediction on CT images

ANNALS OF ONCOLOGY

IF65.4

2023-10-010

PRE

The Association Between [68Ga]PSMA PET/CT Response and Biochemical Progression in Patients with High-Risk Prostate Cancer Receiving Neoadjuvant Therapy

JOURNAL OF NUCLEAR MEDICINE

IF9.1

2023-07-203

PRE

Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International Consensus

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2023-07-0112

OAAI

Spohn, Simon K. B.; Draulans, Cederic; Kishan, Amar U.; Spratt, Daniel; Ross, Ashley; Maurer, Tobias; Tilki, Derya; Berlin, Alejandro; Blanchard, Pierre; Collins, Sean; Bronsert, Peter; Chen, Ronald; Dal Pra, Alan; de Meerleer, Gert; Eade, Thomas; Haustermans, Karin; Holscher, Tobias; Hocht, Stefan; Ghadjar, Pirus; Davicioni, Elai; Heck, Matthias; Kerkmeijer, Linda G. W.; Kirste, Simon; Tselis, Nikolaos; Tran, Phuoc T.; Pinkawa, Michael; Pommier, Pascal; Deltas, Constantinos; Schmidt-Hegemann, Nina-Sophie; Wiegel, Thomas; Zilli, Thomas; Tree, Alison C.; Qiu, Xuefeng; Murthy, Vedang; Epstein, Jonathan I.; Graztke, Christian; Gao, Xin; Grosu, Anca L.; Kamran, Sophia C.; Zamboglou, Constantinos

Environmental microcystin exposure triggers the poor prognosis of prostate cancer: Evidence from case-control, animal, and in vitro studies

JOURNAL OF ENVIRONMENTAL SCIENCES

IF6.3

2023-05-0110

PRE

A retrospective study to evaluate the effect of preoperative hormonal therapy on continence recovery

FRONTIERS IN ONCOLOGY

IF3.3

2023-01-130

OAAI

Celastrol recruits UBE3A to recognize and degrade the DNA binding domain of steroid receptors

IF7.3

2022-09-165

PRE

Multicentric experience in Retzius-sparing robot-assisted radical prostatectomy performed by expert surgeons for high-risk prostate cancer

MINERVA UROLOGY AND NEPHROLOGY

IF4.2

2022-09-0111

OA

circCYP24A1 promotes Docetaxel resistance in prostate Cancer by Upregulating ALDH1A3

BIOMARKER RESEARCH

IF11.5

2022-07-1316

OAAI

Machine Learning-Based Prediction of Pathological Upgrade From Combined Transperineal Systematic and MRI-Targeted Prostate Biopsy to Final Pathology: A Multicenter Retrospective Study

FRONTIERS IN ONCOLOGY

IF3.3

2022-04-073

OAAI

177Lu-PSMA-I&T Radioligand Therapy for Treating Metastatic Castration-Resistant Prostate Cancer: A Single-Centre Study in East Asians

177Lu-PSMA-I & T放射配体治疗转移性去势抵抗性前列腺癌: 一项针对东亚人的单中心研究

FRONTIERS IN ONCOLOGY

IF3.3

2022-03-2415

OAAI

Pan-cancer analysis identifies LMNB1 as a target to redress Th1/Th2 imbalance and enhance PARP inhibitor response in human cancers

CANCER CELL INTERNATIONAL

IF6

2022-03-0317

OAAI

Editorial: Exploring the Potential of PSMA-PET Imaging on Personalized Prostate Cancer Treatment

FRONTIERS IN ONCOLOGY

IF3.3

2022-02-022

OAAI

Platinum-Based Neoadjuvant Chemotherapy Before Radical Prostatectomy for Locally Advanced Prostate Cancer With Homologous Recombination Deficiency: A Case Report

FRONTIERS IN ONCOLOGY

IF3.3

2022-01-051

OAAI

Prediction of Biochemical Recurrence After Radical Prostatectomy Based on Preoperative 68Ga-PSMA-11 PET/CT

术前68Ga-PSMA-11 PET/CT对前列腺癌根治术后生化复发的预测

FRONTIERS IN ONCOLOGY

IF3.3

2021-09-307

OAAI

Can 68Ga-PSMA-11 PET/CT predict pathological upgrading of prostate cancer from MRI-targeted biopsy to radical prostatectomy?

68Ga-PSMA-11 PET/CT能否预测前列腺癌从MRI靶向活检到根治性前列腺切除术的病理升级？

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2021-04-0411

PREAI

SOX9 in prostate cancer is upregulated by cancer-associated fibroblasts to promote tumor progression through HGF/c-Met-FRA1 signaling

前列腺癌中SOX9被癌症相关成纤维细胞上调，通过HGF/c-Met-FRA1信号促进肿瘤进展

IF4.2

2021-04-0219

OAAI